CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues. Read more about CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues.
First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy. Read more about First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy.
The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression. Read more about The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression.
Forced mitotic entry of S-phase cells as a therapeutic strategy induced by inhibition of WEE1. Read more about Forced mitotic entry of S-phase cells as a therapeutic strategy induced by inhibition of WEE1.
Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. Read more about Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors.
Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen. Read more about Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen.
Kinetics of inhibitor cycling underlie therapeutic disparities between EGFR-driven lung and brain cancers. Read more about Kinetics of inhibitor cycling underlie therapeutic disparities between EGFR-driven lung and brain cancers.
Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors. Read more about Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors.
An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. Read more about An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway.
Functional viability profiles of breast cancer. Read more about Functional viability profiles of breast cancer.
